# inCarey

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/incarey

- Industry: Pharmaceuticals
- Headquarters: Hangzhou, China
- Website: www.ykyao.com
- Total disclosed funding: $77M
- Latest round: Series C (Dec 22, 2021)
- Investors on record: 4

## About

Based in Hangzhou, China and established in 2011, inCarey operates as an online pharmaceutical store and healthcare management services provider. As of 2021, the company is headquartered in Shanghai, with branches in Hangzhou and Hainan. The company has completed 3 rounds of funding as of 2021. The company is mainly involved in the field of rheumatology orthopedics, neurology and oncology.

The company focuses on providing one-stop Internet medical, pharmaceutical and innovative payment services for patients with chronic diseases with long courses and severe illnesses. Besides, the company self developed medical platform provides full-course, full-prescription, and full-channel services, and provides continuous services to patients with chronic diseases through a network of doctors, specialist pharmacists, digital tools and platforms.

## Funding rounds

- Series C, Dec 22, 2021, $31M — New Enterprise Associates, Long Hill Capital
- Series B, Sep 14, 2020, $30M — Long Hill Capital
- Series A, Dec 1, 2015, $16M — NLVC, Huagai Capital

## Investors

- NLVC (https://capitalatlas.ai/funds/nlvc) — Series A
- Huagai Capital (https://capitalatlas.ai/funds/huagai-capital) — Series A
- Long Hill Capital (https://capitalatlas.ai/funds/long-hill-capital) — Series B, Series C
- New Enterprise Associates (https://capitalatlas.ai/funds/new-enterprise-associates) — Series C